ARTICLE | Company News
Takeda sales and marketing update
July 27, 2015 7:00 AM UTC
Takeda launched once-weekly oral Zafatek trelagliptin in Japan to treat Type II diabetes. The Japanese National Health Insurance (NHI) list price of the dipeptidyl peptidase-4 (DPP-4) inhibitor is Y...